查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417485

HIV 诊断市场报告：2030 年趋势、预测与竞争分析

HIV Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

HIV诊断趋势与预测

到 2030 年，全球爱滋病毒诊断市场预计将达到 76 亿美元，2024 年至 2030 年复合年增长率为 10.1%。该市场的主要驱动力是捐血和输血数量的增加、照护现场设备和消耗品的好处以及与爱滋病毒相关的政府措施的数量增加。全球爱滋病毒诊断市场的未来看起来充满希望，诊断实验室和医院市场充满机会。

HIV 诊断市场洞察

Lucintel 预测抗体检测将在预测期内达到最高成长。

由于医疗基础设施的成长和爱滋病毒感染率高增加了对高效医疗服务的需求，北美在预测期内可能仍然是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球 HIV 诊断市场预计将达到 76 亿美元。

Q2.市场成长预测如何？

A2. 预计 2024 年至 2030 年，全球爱滋病毒诊断市场将以 10.1% 的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是捐血和输血数量的增加、照护现场设备和消耗品的好处以及与爱滋病毒相关的政府措施的增加。

Q4.市场的主要细分市场是什么？

A4. 全球爱滋病毒诊断市场的未来充满希望，诊断实验室和医院市场充满机会。

Q5.市场上主要企业有哪些？

A5.爱滋病诊断的主要企业如下。

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计抗体测试将在预测期内达到最高成长。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 在预测期内，北美将继续成为最大的地区，因为医疗保健基础设施的增长和爱滋病毒感染率高增加了对高效医疗保健服务的需求。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球爱滋病毒诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球爱滋病毒诊断市场趋势（2018-2023）与预测（2024-2030）
  • 全球爱滋病毒诊断市场（按产品）
    • 消耗品
    • 装置
    • 软体和服务
  • 按测试类型分類的全球爱滋病毒诊断市场
    • 抗体测试
    • 病毒量测试
    • CD4测试
    • 其他的
  • 按最终用途分類的全球爱滋病毒诊断市场
    • 诊断实验室
    • 医院
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球爱滋病毒诊断市场（按地区）
  • 北美HIV诊断市场
  • 欧洲爱滋病毒诊断市场
  • 亚太地区爱滋病毒诊断市场
  • 其他地区HIV诊断市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球爱滋病毒诊断市场成长机会（按产品）
    • 按测试类型分類的全球爱滋病毒诊断市场成长机会
    • 全球爱滋病毒诊断市场成长机会（依最终用途）
    • 全球爱滋病毒诊断市场按地区成长机会
  • 全球爱滋病毒诊断市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球爱滋病毒诊断市场的能力
    • 全球爱滋病毒诊断市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific
简介目录

HIV Diagnostic Trends and Forecast

The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets. The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

A more than 150-page report is developed to help in your business decisions.

HIV Diagnostic by Segment

The study includes a forecast for the global HIV diagnostic by product, test type, end use, and region.

HIV Diagnostic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software & Services

HIV Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antibody Tests
  • Viral Load Tests
  • CD4 Tests
  • Others

HIV Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Others

HIV Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HIV Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HIV diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HIV diagnostic companies profiled in this report include-

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific

HIV Diagnostic Market Insights

Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Features of the Global HIV Diagnostic Market

Market Size Estimates: HIV Diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HIV Diagnostic market size by product, test type, end use, and region in terms of value ($B).

Regional Analysis: HIV Diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, test type, end use, and regions for the HIV diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HIV diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HIV diagnostic market size?

Answer: The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q2. What is the growth forecast for HIV diagnostic market?

Answer: The global HIV diagnostic market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HIV diagnostic market?

Answer: The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

Q4. What are the major segments for HIV diagnostic market?

Answer: The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets.

Q5. Who are the key HIV diagnostic market companies?

Answer: Some of the key HIV diagnostic companies are as follows.

  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Abbott Laboratories
  • Danaher
  • Thermo-Fisher Scientific

Q6. Which HIV diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

Q7. In HIV diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HIV diagnostic market by product (consumables, instruments, and software & services), test type (antibody tests, viral load tests, CD4 tests, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HIV Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HIV Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HIV Diagnostic Market by Product
    • 3.3.1: Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software & Services
  • 3.4: Global HIV Diagnostic Market by Test Type
    • 3.4.1: Antibody Tests
    • 3.4.2: Viral Load Tests
    • 3.4.3: CD4 Tests
    • 3.4.4: Others
  • 3.5: Global HIV Diagnostic Market by End Use
    • 3.5.1: Diagnostic Laboratories
    • 3.5.2: Hospitals
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HIV Diagnostic Market by Region
  • 4.2: North American HIV Diagnostic Market
    • 4.2.1: North American HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.2.2: North American HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
  • 4.3: European HIV Diagnostic Market
    • 4.3.1: European HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.3.2: European HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
  • 4.4: APAC HIV Diagnostic Market
    • 4.4.1: APAC HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.4.2: APAC HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
  • 4.5: ROW HIV Diagnostic Market
    • 4.5.1: ROW HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
    • 4.5.2: ROW HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HIV Diagnostic Market by Product
    • 6.1.2: Growth Opportunities for the Global HIV Diagnostic Market by Test Type
    • 6.1.3: Growth Opportunities for the Global HIV Diagnostic Market by End Use
    • 6.1.4: Growth Opportunities for the Global HIV Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global HIV Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HIV Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HIV Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthineers
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Abbott Laboratories
  • 7.4: Danaher
  • 7.5: Thermo-Fisher Scientific